SGLT-2 Inhibitor with Incretins.
-
Upload
constance-king -
Category
Documents
-
view
226 -
download
0
Transcript of SGLT-2 Inhibitor with Incretins.
![Page 1: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/1.jpg)
![Page 2: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/2.jpg)
![Page 3: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/3.jpg)
![Page 4: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/4.jpg)
![Page 5: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/5.jpg)
![Page 6: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/6.jpg)
![Page 7: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/7.jpg)
![Page 8: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/8.jpg)
![Page 9: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/9.jpg)
![Page 10: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/10.jpg)
![Page 11: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/11.jpg)
![Page 12: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/12.jpg)
SGLT-2 Inhibitor with Incretins
![Page 13: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/13.jpg)
![Page 14: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/14.jpg)
![Page 15: SGLT-2 Inhibitor with Incretins.](https://reader035.fdocuments.net/reader035/viewer/2022062422/56649f205503460f94c38ac8/html5/thumbnails/15.jpg)
Add on to insulin
EFFICACY AND TOLERABILITYOF GLP-1 RECEPTOR AGONISTSAND DPP-4 INHIBITORS AS ADDON THERAPY TO INSULIN
Complementing Insulin Therapy to Achieve GlycemicControl
Anthony H. Barnett Adv Ther (2013) 30:557–576Glucagon-like peptide-1 and glucose-dependentinsulinotropic polypeptide (GIP) are incretinhormones that are secreted into the circulationby the intestine in response to nutrient intake.GLP-1 stimulates glucose-dependent insulinsecretion, inhibits glucagon secretion, delaysgastric emptying, increases feelings of satiety,and decreases food intake [82]. GLP-1 and GIPare rapidly degraded by the enzyme DPP-4,which exists as both a circulating and amembrane-bound form expressed in manytissues [82]. In individuals with T2DM, there isa decreased response of b-cells to GIP, whereasthe insulinotropic effect of GLP-1 is nearnormal [83]. Consequently, efforts have beendirected toward enhancing the effect of GLP-1by developing degradation-resistant GLP-1receptor agonists and inhibitors of DPP-4.Of interest are the findings from some [84,85], but not all studies [86] that a-glucosidaseinhibitors may increase GLP-1 release in healthypeople as well as in patients with T2DMfollowing a mixed test meal. In addition,metformin has been shown to increase plasmalevels of GLP-1 after an oral glucose load inobese individuals without T2DM and inpatients with T2DM [87, 88]. The contributionof this effect to the antihyperglycemic efficacyof these drugs is not clear.